Reducing the risks for contrast-induced nephropathy

CardioVascular and Interventional Radiology

Volumn 28, Issue SUPPL. 2, 2005, Pages

  Stacul, Fulvio ^a,b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Computed tomography; Contrast media; Contrast induced nephropathy; Renal insufficiency

Indexed keywords

ACETYLCYSTEINE; AMINOGLYCOSIDE; ANTIINFLAMMATORY AGENT; ATRIAL NATRIURETIC FACTOR; BICARBONATE; CALCIUM CHANNEL BLOCKING AGENT; CISPLATIN; CONTRAST MEDIUM; CREATININE; DOPAMINE; ENDOTHELIN RECEPTOR ANTAGONIST; FENOLDOPAM; PROSTAGLANDIN E1; THEOPHYLLINE;

CONGESTIVE HEART FAILURE; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DEHYDRATION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; HEMODIALYSIS; HEMOFILTRATION; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; HYDRATION; KIDNEY DISEASE; KIDNEY FAILURE; LENGTH OF STAY; MORBIDITY; MORTALITY; NEPHROTOXICITY; PRIORITY JOURNAL; PROPHYLAXIS; RADIATION DOSE; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION;

CONTRAST MEDIA; CREATININE; HUMANS; KIDNEY DISEASES; RISK FACTORS;

EID: 27844542275     PISSN: 01741551     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00270-005-0197-7     Document Type: Review

References (57)

1. Morcos SK, Thomsen HS, Webb JA (1999) Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 9:1602-1613
2. Mehran R, Aymong ED, Nikolsky E, et al. (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44:1393-1399
3. Levy EM, Viscoli CM, Horwitz RI (1996) The effect of acute renal failure on mortality. A cohort analysis. JAMA 275:1489-1494
4. McCullough PA, Wolyn R, Rocher LL, et al. (1997) Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103:368-375
5. Dangas G, Iakovou I, Nikolsky E, et al. (2005) Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 95:13-19
6. Powe NR, Moore RD, Steinberg EP (1993) Adverse reactions to contrast media: factors that determine the cost of treatment. AJR Am J Roentgenol 161:1089-1095
7. Morcos SK (2004) Prevention of contrast media nephrotoxicity - the story so far. Clin Radiol 59:381-389
8. Lee JK, Warshauer DM, Bush WH Jr., et al. (1995) Determination of serum creatinine level before intravenous administration of iodinated contrast medium. A survey. Invest Radiol 30:700-705
9. Thomsen HS, Morcos SK (2005) In which patients should serum creatinine be measured before iodinated contrast medium administration? Eur Radiol 15:749-754
10. Choyke PL, Cady J, DePollar SL, et al. (1998) Determination of serum creatinine prior to iodinated contrast media: is it necessary in all patients? Tech Urol 4:65-69
11. Rudnick MR, Goldfarb S, Wexler L, et al. (1995) Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 47:254-261
12. Bartholomew BA, Harjai KJ, Dukkipati S, et al. (2004) Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 93:1515-1519
13. Cavusoglu E, Chhabra S, Marmur JD, et al. (2004) The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Minerva Cardioangiol 52:419-432
14. Alamartine E, Phayphet M, Thibaudin D, et al. (2003) Contrast medium-induced acute renal failure and cholesterol embolism after radiological procedures: incidence, risk factors, and compliance with recommendations. Eur J Intern Med 14:426-431
15. King B, Segal A, Berg G, et al. (2004). Manual on Contrast Media. American College of Radiology: Reston, Virginia
16. Thomsen HS, Dorph S, Larsen S, et al. (1995) Urine profiles and kidney histology after ionic and nonionic radiologic and magnetic resonance contrast media in rats with cisplatin nephropathy. Acad Radiol 2:675-682
17. Gami AS, Garovic VD (2004) Contrast nephropathy after coronary angiography. Mayo Clin Proc 79:211-219
18. Maeder M, Klein M, Fehr T, et al. (2004) Contrast nephropathy: Review focusing on prevention. J Am Coll Cardiol 44:1763-1771
19. Trivedi HS, Moore H, Nasr S, et al. (2003) A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 93:C29-34
20. Mueller C, Buerkle G, Buettner HJ, et al. (2002) Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162:329-336
21. Merten GJ, Burgess WP, Gray LV, et al. (2004) Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291:2328-2334
22. Gruberg L, Mintz GS, Mehran R, et al. (2000) The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36:1542-1548
23. Freeman RV, O'Donnell M, Share D, et al. (2002) Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 90:1068-1073
24. Barrett BJ, Carlisle EJ (1993) Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188:171-178
25. Aspelin P, Aubry P, Fransson SG, et al. (2003) Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348:491-499
26. Waybill MM, Waybill PN (2001) Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol 12:3-9
27. Ferrone M (2004) Pharmacotherapeutic options to prevent radiocontrast-induced acute renal failure. Formulary 39:163-185
28. Idée I, Lancelot E, Pines E, et al. (2004) Prophylaxis of iodinated contrast media-induced nephropathy. A pharmacological point of view. Invest Radiol 39:155-170
29. Russo D, Testa A, Della Volpe L, et al. (1990) Randomised prospective study on renal effects of two different contrast media in humans: protective role of a calcium channel blocker. Nephron 55:254-257
30. Russo D, Minutolo R, Cianciaruso B, et al. (1995) Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol 6:1451-1458
31. Kapoor A, Sinha N, Sharma RK, et al. (1996) Use of dopamine in prevention of contrast induced acute renal failure - a randomised study. Int J Cardiol 53:233-236
32. Hall KA, Wong RW, Hunter GC, et al. (1992) Contrast-induced nephrotoxicity: the effects of vasodilator therapy. J Surg Res 53:317-320
33. Hans B, Hans SS, Mittal VK, et al. (1990) Renal functional response to dopamine during and after arteriography in patients with chronic renal insufficiency. Radiology 176:651-654
34. Hans SS, Hans BA, Dhillon R, et al. (1998) Effect of dopamine on renal function after arteriography in patients with pre-existing renal insufficiency. Am Surg 64:432-436
35. Weisberg LS, Kurnik PB, Kurnik BR (1993) Dopamine and renal blood flow in radiocontrast-induced nephropathy in humans. Ren Fail 15:61-68
36. Gleeson T, O'Dwyer I, Bulugahapitiya S, et al. (2004) Contrast-induced nephropathy. Br J Cardiol (Acute Interv Cardiol) 11:AIC-53-AIC 61
37. Weisberg LS, Kurnik PB, Kurnik BR (1994) Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 45:259-265
38. Kurnik BR, Allgren RL, Genter FC, et al. (1998) Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 31:674-680
39. Stone GW, McCullough PA, Tumlin JA, et al. (2003) Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA 290:2284-2291
40. Allaqaband S, Tumuluri R, Malik AM, et al. (2002) Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Catheter Cardiovasc Interv 57:279-283
41. Koch JA, Plum J, Grabensee B, et al. (2000) Prostaglandin E1: a new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media? PGE1 Study Group. Nephrol Dial Transplant 15:43-49
42. Wang A, Holcslaw T, Bashore TM, et al. (2000) Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int 57:1675-1680
43. Ix JH, McCulloch CE, Chertow GM (2004) Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis. Nephrol Dial Transplant 19:2747-2753
44. Hoffmann U, Fischereder M, Kruger B, et al. (2004) The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 15:407-410
45. Tepel M, van der Giet M, Schwarzfeld C, et al. (2000) Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343:180-184
46. Kay J, Chow WH, Chan TM, et al. (2003) Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA 289:553-558
47. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW (2002) Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol 89:356-358
48. Shyu KG, Cheng JJ, Kuan P (2002) Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 40:1383-1388
49. Birck R, Krzossok S, Markowetz F, et al. (2003) Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 362:598-603
50. Kshirsagar AV, Poole C, Mottl A, et al. (2004) N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. J Am Soc Nephrol 15:761-769
51. Fishbane S, Durham JH, Marzo K, et al. (2004) N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol 15:251-260
52. Nguyen-Ho P, Dzavik V, Seidelin P, et al. (2003) N-Acetylcysteine does not prevent long-term clinical events despite reducing periprocedural contrast-associated nephropathy. Circulation 108(Suppl IV):445Abstract 2047
53. Briguori C, Colombo A, Violante A, et al. (2004) Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J 25:206-211
54. Lehnert T, Keller E, Gondolf K, et al. (1998) Effect of haemodialysis after contrast medium administration in patients with renal insufficiency. Nephrol Dial Transplant 13:358-362
55. Vogt B, Ferrari P, Schonholzer C, et al. (2001) Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 111:692-698
56. Morcos S, Thomsen H, Webb J, et al. (2004) Dialysis and contrast media. JBR-BTR 87:87-87
57. Marenzi G, Marana I, Lauri G, et al. (2003) The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 349:1333-1340